{"id":241109,"date":"2026-07-17T20:07:45","date_gmt":"2026-07-18T01:07:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/ucla-scientists-develop-offtheshelf-immunotherapy-for-ovarian-cancer"},"modified":"2026-07-17T20:07:45","modified_gmt":"2026-07-18T01:07:45","slug":"ucla-scientists-develop-offtheshelf-immunotherapy-for-ovarian-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/ucla-scientists-develop-offtheshelf-immunotherapy-for-ovarian-cancer","title":{"rendered":"UCLA scientists develop offtheshelf immunotherapy for ovarian cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/ucla-scientists-develop-offtheshelf-immunotherapy-for-ovarian-cancer.jpg\"><\/a><\/p>\n<p>When the team tested the novel CAR-NKT therapy on 35 ovarian patient-derived tumor samples, the results were striking. The CAR-NKT cells successfully killed ovarian cancer cells in every single sample \u2014 including samples from both newly diagnosed patients and patients whose cancers had recurred after chemotherapy.<\/p>\n<p>\u201cCombating this high rate of recurrence in ovarian cancer is my career mission,\u201d said co-senior author Memarzadeh, a professor of obstetrics and gynecology and a member of the UCLA Broad Stem Cell Research Center and the UCLA Health Jonsson Comprehensive Cancer Center. \u201cWhen I see these results, I know we\u2019re getting closer to offering patients like mine a more effective and permanent solution.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>When the team tested the novel CAR-NKT therapy on 35 ovarian patient-derived tumor samples, the results were striking. The CAR-NKT cells successfully killed ovarian cancer cells in every single sample \u2014 including samples from both newly diagnosed patients and patients whose cancers had recurred after chemotherapy. \u201cCombating this high rate of recurrence in ovarian cancer [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-241109","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/241109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=241109"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/241109\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=241109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=241109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=241109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}